Banka Bioloo Ltd
Incorporated in 2012, Banka Bioloo Ltd does manufacturing, supply, installation and O&M
of Bio toilets and Controlled discharge toilet system[1]
- Market Cap ₹ 80.9 Cr.
- Current Price ₹ 74.0
- High / Low ₹ 96.6 / 41.0
- Stock P/E 87.9
- Book Value ₹ 30.7
- Dividend Yield 0.00 %
- ROCE 4.62 %
- ROE 2.06 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.99% over last 3 years.
- Contingent liabilities of Rs.33.4 Cr.
- Company has high debtors of 157 days.
- Promoter holding has decreased over last 3 years: -3.85%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.19 | 14.27 | 15.12 | 16.53 | 35.42 | 47.86 | 30.46 | 38.63 | 42.15 | 49.97 | 55.00 | 59.76 | 63.56 | |
| Sales growth | +74.24% | +5.96% | +9.33% | +114.28% | +35.12% | -36.36% | +26.82% | +9.11% | +18.55% | +10.07% | +8.65% | +15.21% | |
| 7.72 | 13.22 | 10.63 | 13.12 | 29.19 | 39.26 | 27.01 | 33.10 | 35.89 | 46.55 | 53.05 | 56.58 | 58.95 | |
| Operating Profit | 0.47 | 1.05 | 4.49 | 3.41 | 6.23 | 8.60 | 3.45 | 5.53 | 6.26 | 3.42 | 1.95 | 3.18 | 4.61 |
| OPM % | 5.74% | 7.36% | 29.70% | 20.63% | 17.59% | 17.97% | 11.33% | 14.32% | 14.85% | 6.84% | 3.55% | 5.32% | 7.25% |
| 0.01 | 0.06 | 0.04 | 0.16 | 0.37 | 0.45 | 0.58 | 0.45 | 0.81 | 0.77 | -6.80 | 0.95 | -0.06 | |
| Interest | 0.23 | 0.46 | 0.07 | 0.80 | 0.62 | 0.96 | 1.56 | 1.78 | 1.49 | 2.05 | 2.72 | 2.57 | 2.53 |
| Depreciation | 0.13 | 0.16 | 2.77 | 0.19 | 0.32 | 0.47 | 0.60 | 0.94 | 1.43 | 1.72 | 1.82 | 1.78 | 1.85 |
| Profit before tax | 0.12 | 0.49 | 1.69 | 2.58 | 5.66 | 7.62 | 1.87 | 3.26 | 4.15 | 0.42 | -9.39 | -0.22 | 0.17 |
| Tax % | 41.67% | 36.73% | 38.46% | 26.36% | 20.49% | 20.73% | -17.65% | 6.13% | 25.78% | 21.43% | -1.06% | -272.73% | |
| 0.08 | 0.32 | 1.04 | 1.89 | 4.51 | 6.05 | 2.21 | 3.06 | 3.08 | 0.33 | -9.30 | 0.38 | 0.62 | |
| EPS in Rs | 0.11 | 0.44 | 1.44 | 1.83 | 4.38 | 5.87 | 2.15 | 2.82 | 2.84 | 0.30 | -8.55 | 0.35 | 0.57 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 9.11% | 6.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -21% |
| 3 Years: | -40% |
| TTM: | 138% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | 2% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 3% |
| 3 Years: | -1% |
| Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.13 | 0.13 | 0.13 | 4.11 | 4.11 | 4.11 | 10.28 | 10.85 | 10.85 | 10.85 | 10.87 | 10.92 |
| Reserves | 2.37 | 2.69 | 3.81 | 13.73 | 17.74 | 23.78 | 19.75 | 26.61 | 29.74 | 30.35 | 21.73 | 22.66 |
| 1.89 | 3.90 | 4.45 | 4.27 | 2.14 | 11.59 | 11.69 | 16.08 | 15.21 | 20.23 | 24.95 | 23.59 | |
| 1.40 | 2.85 | 2.66 | 1.64 | 4.29 | 7.30 | 4.65 | 6.05 | 6.77 | 9.34 | 13.74 | 16.76 | |
| Total Liabilities | 5.79 | 9.57 | 11.05 | 23.75 | 28.28 | 46.78 | 46.37 | 59.59 | 62.57 | 70.77 | 71.29 | 73.93 |
| 1.50 | 1.43 | 1.45 | 1.75 | 2.77 | 4.02 | 5.09 | 6.17 | 10.13 | 10.66 | 9.81 | 18.26 | |
| CWIP | 0.13 | 0.14 | 0.19 | 0.00 | 0.34 | 0.00 | 0.00 | 2.42 | 0.69 | 6.51 | 7.64 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 4.36 | 5.36 | 5.34 | 0.98 | 0.98 |
| 4.16 | 8.00 | 9.41 | 22.00 | 25.17 | 42.76 | 41.25 | 46.64 | 46.39 | 48.26 | 52.86 | 54.69 | |
| Total Assets | 5.79 | 9.57 | 11.05 | 23.75 | 28.28 | 46.78 | 46.37 | 59.59 | 62.57 | 70.77 | 71.29 | 73.93 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.41 | -0.60 | 0.43 | -2.83 | -0.97 | -6.00 | 5.83 | -0.96 | 4.23 | 5.32 | 1.06 | 2.54 | |
| -0.71 | -0.07 | -0.20 | -5.42 | -3.47 | -5.06 | -4.71 | -10.92 | -5.39 | -8.89 | -3.37 | 2.70 | |
| 2.18 | 0.68 | 0.12 | 10.53 | -3.03 | 7.59 | -3.65 | 1.36 | -2.21 | 3.01 | 2.05 | -5.19 | |
| Net Cash Flow | 0.07 | 0.02 | 0.35 | 2.27 | -7.47 | -3.47 | -2.53 | -10.51 | -3.36 | -0.56 | -0.26 | 0.05 |
| Free Cash Flow | -2.13 | -0.70 | 0.19 | -3.14 | -2.64 | -7.41 | 5.32 | -4.11 | 0.56 | -2.75 | -1.03 | 1.45 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -291% | -40% | 14% | -107% | -44% | -86% | 204% | -5% | 81% | 177% | 98% | 48% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66.85 | 146.56 | 162.46 | 204.47 | 100.06 | 114.17 | 139.96 | 164.22 | 190.42 | 143.09 | 170.42 | 156.79 |
| Inventory Days | 139.56 | 59.76 | 45.25 | 101.47 | 105.03 | 356.99 | ||||||
| Days Payable | 85.17 | 106.19 | 94.67 | 80.33 | 52.08 | 192.18 | ||||||
| Cash Conversion Cycle | 121.24 | 100.13 | 113.04 | 225.61 | 153.01 | 114.17 | 139.96 | 164.22 | 190.42 | 307.91 | 170.42 | 156.79 |
| Working Capital Days | 103.39 | 64.71 | 101.39 | 187.69 | 114.69 | 147.95 | 243.73 | 200.03 | 168.69 | 140.39 | 70.81 | 80.32 |
| ROCE % | 17.10% | 23.30% | 22.16% | 27.25% | 27.04% | 8.45% | 10.58% | 10.32% | 4.21% | 0.87% | 4.62% |
Insights
In beta| Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Employees on Roll count |
|
||||||
| Bio Toilets Installed units |
|||||||
| Total Unexecuted Order Book INR crores |
|||||||
| Fecal Sludge Treated (Cumulative) MLD |
|||||||
| Railways Bio-Toilet Systems O&M Daily units/day |
|||||||
| Railways New Order Bookings INR crores |
|||||||
| WaSH New Order Bookings INR crores |
|||||||
Extracted by Screener AI
Documents
Announcements
-
ESOP/ESOS/ESPS
- Banka BioLoo allotted 5,000 equity shares on 16 October 2026 under its ESOP 2023.
-
ESOP/ESOS/ESPS
- NRC approved grant of 2,000 ESOP options on 16 October 2026.
-
ESOP/ESOS/ESPS
- NRC approved grant of 2,000 ESOP options on 16 October 2026, vesting over 48 months.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Company confirmed Regulation 74(5) non-applicability for quarter ended 30 September 2026.
-
Trading Window
- Trading window closed from 1 October 2026 until 48 hours after Q2 FY27 results.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
-
Annual Report 2024
from nse
-
Annual Report 2023
from nse
-
Annual Report 2022
from nse
-
Annual Report 2021
from nse
Business Overview:[1]
BBL is a technology driven social enterprise focused on delivering integrated sanitation
and water solutions. It has evolved from a
bio-toilet innovator into a full stack sanitation
and water regeneration provider. The company offers end-to-end capabilities across design, engineering, execution, lifecycle management.
It is transforming wastewater from a disposal problem into a sustainable water resource.